C3b antibodies and methods for the prevention and treatment of complementassociated disorders

Details for Australian Patent Application No. 2008262048 (hide)

Owner GENENTECH, INC.

Inventors Van Lookeren Campagne, Menno

Agent Griffith Hack

Pub. Number AU-A-2008262048

PCT Pub. Number WO2008/154251

Priority 60/933,721 07.06.07 US; 60/055,068 21.05.08 US

Filing date 4 June 2008

Wipo publication date 18 December 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/154251 Priority application(s): WO2008/154251

3 February 2011 Amendment Made

  The nature of the amendment is: Amend the priority details under INID (31) from 60/055,068 to 61/055,068

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262056-Biphenylcarboxamide derivatives as hedgehog pathway modulators

2008262038-5-heteroaryl substituted indazoles as kinase inhibitors